(Q39411673)

English

Resistance to tamoxifen-induced apoptosis is associated with direct interaction between Her2/neu and cell membrane estrogen receptor in breast cancer

scientific article published on January 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Resistance to tamoxifen-induced apoptosis is associated with direct interaction between Her2/neu and cell membrane estrogen receptor in breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

based on heuristic

inferred from title

apoptotic process

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Yih-Lin Chung

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Meei-Ling Sheu

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Shun-Chun Yang

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Chi-Hung Lin

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sang-Hue Yen

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

0 references

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

97

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

306-312

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1614

21 January 2018

Endocrine pharmacology of antiestrogens as antitumor agents

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1614

21 January 2018

Activation of the p38 mitogen-activated protein kinase pathway by estrogen or by 4-hydroxytamoxifen is coupled to estrogen receptor-induced apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1614

21 January 2018

Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1614

21 January 2018

Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1614

21 January 2018

Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1614

21 January 2018

Phenylacetate synergizes with retinoic acid in inducing the differentiation of human neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1614

21 January 2018

Differential modulation of transcriptional activity of oestrogen receptors by direct protein-protein interactions with retinoid receptors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1614

21 January 2018

Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1614

21 January 2018

Metabolic and proliferative responses to estrogen by hepatocytes selected for plasma membrane binding-sites specific for estradiol-17?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1614

21 January 2018

Binding of 17-β-estradiol to the outer surface and nucleus of human spermatozoa

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1614

21 January 2018

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1614

21 January 2018

Bryostatin 1-tamoxifen combinations show synergistic effects on the inhibition of growth of P388 cells in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1614

21 January 2018

Analogues of butyric acid that increase the expression of transfected DNAs

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1614

21 January 2018

Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failure

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1614

21 January 2018

Identifiers

10.1002/IJC.1614

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39411673&oldid=1966912457"